Internal Medicine, Rheumatology · Williamsville, NY
NPI
1013176692
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
495 International Dr
Williamsville, NY, 14221
Phone (716) 810-9292
Groups this clinician bills Medicare through
Medicare paid, 2024
$562K
62,771 services
Medicare patients, 2024
284
Average age 72
Drug cost, 2024
$4.5M
4,895 prescriptions
Company payments, 2025
$23K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sunita Chadha was code J3262 (injection, tocilizumab, 1 mg), 39,081 times for 11 patients. In total Sunita Chadha billed 62,771 services in 35 codes, and Medicare paid $562K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 39,081 | 11 | $3.97 | $155K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,688 | 27 | $0.10 | $175 |
| J0897 Injection, denosumab, 1 mg | Office | 1,680 | 16 | $20.49 | $34K |
| 99213 Office E&M - Established | Office | 314 | 214 | $52.99 | $17K |
| 96365 Intravenous Infusion, Hydration | Office | 282 | 52 | $37.79 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 240 | 171 | $10.63 | $2,552 |
| 99214 Office E&M - Established | Office | 110 | 88 | $67.37 | $7,411 |
| 96366 Intravenous Infusion, Hydration | Office | 62 | 12 | $13.23 | $820 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 60 | 12 | $4.62 | $277 |
| 96372 Injection Administration | Office | 42 | 28 | $8.91 | $374 |
| 20610 Joint Injection | Office | 37 | 26 | $49.32 | $1,825 |
| 99204 Office E&M - New | Office | 23 | 23 | $94.02 | $2,162 |
By year: 2022 $632K for 63,941 services; 2023 $798K for 57,787 services; 2024 $562K for 62,771 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sunita Chadha prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 1,040 prescriptions and refills. In total Sunita Chadha wrote 4,895 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 1,040 | 1,845 | 261 | $29K |
| Prednisone Generic | 731 | 840 | 225 | $4,711 |
| Hydroxychloroquine Sulfate Generic | 649 | 1,155 | 157 | $27K |
| Sulfasalazine Generic | 306 | 544 | 65 | $11K |
| Folic Acid Generic | 221 | 443 | 60 | $1,338 |
| Allopurinol Generic | 160 | 302 | 52 | $2,694 |
| Leflunomide Generic | 133 | 249 | 31 | $7,495 |
| Meloxicam Generic | 123 | 167 | 24 | $404 |
| Sulfasalazine Dr Sulfasalazine | 121 | 198 | 37 | $5,050 |
| Alendronate Sodium Generic | 110 | 259 | 41 | $772 |
| Gabapentin Generic | 95 | 115 | 27 | $1,118 |
| Febuxostat Generic | 78 | 118 | 20 | $5,695 |
| Humira(Cf) Pen Adalimumab | 64 | 65 | Under 11 | $455K |
| Colchicine Generic | 64 | 73 | 23 | $5,613 |
| Prolia Denosumab | 59 | 354 | 39 | $102K |
Brand drugs: - claims; generic drugs: 3,746 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sunita Chadha $23K ($23K in general payments such as food, travel and fees) from 11 companies. The largest payer was Amgen Inc. with $21K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 51 | $21K |
| GlaxoSmithKline, LLC. GSK | 7 | $1,420 |
| Abbvie Inc. ABBV | 8 | $156 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $124 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $78.77 |
| Pfizer Inc. PFE | 4 | $78.04 |
| UCB, Inc. UCB.BR | 2 | $55.47 |
| Janssen Biotech, Inc. JNJ | 1 | $54.99 |
| Genentech USA, Inc. ROG.SW | 2 | $51.31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.